Abstract
Problem statement: Gastrointestinal disorders mainly diarrhea is the most common cause of morbidity and mortality among infants and children in the developing countries occurs due to infection by enteropathogens. Ccontrol of these pathogens could be achieved by nonpathogenic Escherichia coli producing bacteriocins. Approach: Primary aim of this study was to isolate E. coli strains which inhibit enteropathogens. For this purpose, E. coli strains were isolated and tested for probiotic properties such as antimicrobial activity against enteropathogens, antibiotic susceptibility and resistance to low pH, absence of virulence traits, susceptibility to proteolytic activity and detection of colicins type. Results: Approximately 280 E. coli strains were collected from rat feacal samples at different ages and were screened for their antimicrobial activity. Out of these, 47 isolates showed antimicrobial effect against E. coli DH5α and BL21 strains and 16 were effective against different pathogens viz. Salmonella sp., Klebisella pneumoniae, Staphylococcus aureus and Enterobacter sp. These 16 isolates were susceptible to the common Antibiotics and most of them better survived at pH 3 and a few survived even at pH 2. Colony PCR of these isolates with colicinogenic primer demonstrated the presence of multiple colicin types. Out of 16 isolates, 12 had multiple pore forming colicins of E1 and 1a/1b type. In addition to the pore forming E1 and 1a/1b colicins, four E. coli strains 16, 2P and 14, 20 had Emix (nuclease type)/BD type (translation blocker) colicins, respectively. Conclusion: This study showed that E. coli isolates 10, 14 and 14 P possess good probiotic properties and could be effective against enteropathogens.
Highlights
The gastrointestinal tract is a biologically diverse and complicated system which contains around 1014 bacterial cells and up to 1000 species[1]
We report the isolation of were washed in sterile Phosphate-Buffered Saline potential probiotic of E. coli strains from rat faecal (PBS) pH 7 and resuspended in PBS
Antimicrobial activity of the culture filtrates against the test organisms Escherichia coli, Enterobacter asburiae, Klebisella sp., Staphylococcus aureus, Salmonella typhi and Salmonella abony is shown in Table 1 and Fig. 1
Summary
The gastrointestinal tract is a biologically diverse and complicated system which contains around 1014 bacterial cells and up to 1000 species[1]. A (100 μg), gentamicin (10 μg), nitrofurantoin (300 μg), nonpathogenic strain has been well established in nalidixic acid (30 μg), netilin (30 μg), ofloxacin (10 μg) human medicine since 1917[8] This strain was used and tetracycline (30 μg) and tobramycin (10 μg) using successfully under the brand name Mutaflor for treating commercial discs (HiMedia Laboratories). Antimicrobial compounds with inhibitory capabilities against pathogenic Enterobacter spp. and inhibited the Tolerance to acidic pH values: E. coli strains were gastrointestinal enteric infections[9]. Bacteriocins inhibit grown in Luria broth (HiMedia) at 37°C overnight, pathogens within the closely related species such as subcultured into fresh Luria broth and incubated till the Salmonella, Shigella, Klebsiella, Enterobacter and culture was grown up to 0.6 OD at 550nm.
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
